0009

JINLING PHARM. (000919)

Market Closed
6 Dec, 06:57
SSE SSE
¥
4,928. 08
+54.98
+1.13%
¥
393,547,350 Volume
¥ 4.87K
Previous Close
Day Range
4,875.55 4,947.66
Year Range
3,878.23 5,495.06
Want to track 000919 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000919 Chart

JINLING PHARM. Profile

SSE Exchange
CN Country

Overview

Jinling Pharmaceutical Company Limited is a prominent name in the Chinese pharmaceutical industry, known for its significant contribution in manufacturing and selling pharmaceutical products and medical devices. Founded in 1998 and having its headquarters in Nanjing, China, the company has established itself as a crucial provider of medical solutions within the country. With a focus on addressing various health issues through its comprehensive range of products, Jinling Pharmaceutical has earned a reputation for its innovation, quality, and the ability to cater to specific medical needs. The company's commitment to providing effective healthcare solutions is evident through its diverse portfolio, which includes treatments for thrombosis and sequelae, iron deficiency anemia, malignant tumors, and offering effective solutions for wound hemostasis among other medical conditions.

Products and Services

  • Mailuoning Injection/Oral Solutions

    Designed for the treatment of various vascular disorders, including thromboangiitis obliterans, arteriosclerosis obliterans, and cerebral thrombosis, among others. These solutions are indicative of Jinling’s expertise in addressing complex vascular health issues through advanced pharmaceutical formulations.

  • Ferrous Succinate Tablets

    Aimed at preventing and treating iron deficiency anemia, these tablets demonstrate Jinling Pharmaceutical’s commitment to combating prevalent health conditions with effective and accessible solutions.

  • Lentinan Injection

    This product stands out for its application in the treatment of malignant tumors, showcasing Jinling Pharmaceutical's strides in oncology. The use of lentinan injections underscores the company's role in advancing cancer treatment options.

  • Absorbable Gelatin Sponges

    These are crafted for the treatment of wound hemostasis, illustrating Jinling’s innovative approach to surgical and medical care supplies. The absorbable gelatin sponges highlight the company’s contribution towards improving surgical outcomes through effective hemostatic products.

In addition to these specialized products, Jinling Pharmaceutical Company Limited also offers a range of medical and health care services, further broadening its impact on the healthcare industry in China. These services emphasize the company's comprehensive approach to healthcare, providing end-to-end solutions from preventive measures to treatment and recovery support.

Contact Information

Address: Jinling Pharmaceutical Building, Nanjing, China, 210009
Phone: 86 25 8311 8511